Similar articles

• Clinical evaluation of the St. Jude Medical heart valve prosthesis. A two-year follow-up of 150 patients.

  Burckhardt D, Hoffmann A, Vogt S, Pfisterer M, Hasse J, Grädel E. Burckhardt D, et al. J Thorac Cardiovasc Surg. 1984 Sep;88(3):432-8. J Thorac Cardiovasc Surg. 1984. PMID: 6471892
• [Thromboembolic complications in patients at remote periods after insertion of heart valve prosthesis].

  Marcinkevicius A, Paliushchinskaia N, Sirvidis V, Milvydaite A, Zemkauskaite I. Marcinkevicius A, et al. Grudn Khir. 1974 Jul-Aug;0(4):13-7. Grudn Khir. 1974. PMID: 4411276 Russian. No abstract available.
• The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.

  Chaux A, Czer LS, Matloff JM, DeRobertis MA, Stewart ME, Bateman TM, Kass RM, Lee ME, Gray RJ. Chaux A, et al. J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 1):706-17. J Thorac Cardiovasc Surg. 1984. PMID: 6492839
• Clinical evaluation of the Omniscience cardiac valve prosthesis. Follow-up of up to 6 years.

  Akalin H, Corapçioğlu ET, Ozyurda U, Uçanok K, Uysalel A, Kaya B, Eren NT, Erol C. Akalin H, et al. J Thorac Cardiovasc Surg. 1992 Feb;103(2):259-66. J Thorac Cardiovasc Surg. 1992. PMID: 1735991
• The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.

  Jamieson WR, Allen P, Miyagishima RT, Gerein AN, Munro AI, Burr LH, Tyers GF. Jamieson WR, et al. J Thorac Cardiovasc Surg. 1990 Mar;99(3):543-61. J Thorac Cardiovasc Surg. 1990. PMID: 2308373